Sangui Biotech International Stock Today
| SGBI Stock | USD 0 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 44
|
Sangui Biotech is trading at 0.0015 as of the 2nd of December 2024. This is a No Change since the beginning of the trading day. The stock's open price was 0.0015. Sangui Biotech has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Sangui Biotech International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 12th of January 2023 and ending today, the 2nd of December 2024. Click here to learn more.
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany. Sangui Biotech is traded on OTC Exchange in the United States.. The company has 209.9 M outstanding shares. More on Sangui Biotech International
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sangui Pink Sheet Highlights
| CEO | Thomas Striepe |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Sangui Biotech International [SGBI] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 902.58 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sangui Biotech's market, we take the total number of its shares issued and multiply it by Sangui Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sangui Biotech Inter conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 209.9 M outstanding shares.
Sangui Biotech International currently holds about 30.47 K in cash with (140.46 K) of positive cash flow from operations.
Check Sangui Biotech Probability Of Bankruptcy
Ownership AllocationSangui Biotech Inter shows a total of 209.9 Million outstanding shares. Sangui Biotech Inter has 13.03 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sangui Ownership Details
Sangui Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sangui Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Other Information on Investing in Sangui Pink Sheet
Sangui Biotech financial ratios help investors to determine whether Sangui Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sangui with respect to the benefits of owning Sangui Biotech security.